Meet Samuel – Your Personal Investing Prophet
- Start a conversation with TipRanks’ trusted, data-backed investment intelligence
- Ask Samuel about stocks, your portfolio, or the market and get instant, personalized insights in seconds
The latest update is out from Atlas Arteria ( (AU:ALX) ).
Atlas Arteria has notified the market of the issue of 1,146,646 unquoted performance rights under its employee incentive scheme, effective 22 May 2026. The move reinforces the company’s use of equity-based remuneration to align staff interests with long-term shareholder value, while not affecting the stock’s quoted free float as the new securities will not be listed on the ASX.
The most recent analyst rating on (AU:ALX) stock is a Hold with a A$4.80 price target. To see the full list of analyst forecasts on Atlas Arteria stock, see the AU:ALX Stock Forecast page.
More about Atlas Arteria
Atlas Arteria is a listed infrastructure company focused on operating and investing in toll roads and related transport assets. Through its holdings, the group provides long-term exposure to traffic-dependent revenue streams in key markets, positioning it as a specialist player in regulated and concession-based road infrastructure.
Average Trading Volume: 3,075,277
Technical Sentiment Signal: Strong Buy
Current Market Cap: A$6.98B
For a thorough assessment of ALX stock, go to TipRanks’ Stock Analysis page.